Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Costs and concerns in cancer care.

Literature DB >> 27789919

Costs and concerns in cancer care.

Ian Haines¹.

Abstract

Entities: Disease

Keywords: Pharmaceutical Benefits Scheme; cost of drugs

Year: 2016 PMID： 27789919 PMCID： PMC5079785 DOI： 10.18773/austprescr.2016.056

Source DB: PubMed Journal: Aust Prescr ISSN： 0312-8008

Keyword Cloud
References

× No keyword cloud information.

11 in total

1. A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).

Authors: N I Cherny; R Sullivan; U Dafni; J M Kerst; A Sobrero; C Zielinski; E G E de Vries; M J Piccart
Journal: Ann Oncol Date: 2015-05-30 Impact factor: 32.976

2. Cancer control is not beyond us … but could be if we don't invest wisely.

Authors: David C Currow; Sanchia Aranda
Journal: Med J Aust Date: 2015-02-02 Impact factor: 7.738

3. Alignment of practice guidelines with targeted-therapy drug funding policies in Ontario.

Authors: R Ramjeesingh; R M Meyer; M Brouwers; B E Chen; C M Booth
Journal: Curr Oncol Date: 2013-02 Impact factor: 3.677

4. Cancer drugs in the United States: Justum Pretium--the just price.

Authors: Hagop M Kantarjian; Tito Fojo; Michael Mathisen; Leonard A Zwelling
Journal: J Clin Oncol Date: 2013-05-06 Impact factor: 44.544

5. A decade of promises in personalised cancer medicine: is the honeymoon over?

Authors: Robyn L Ward
Journal: Med J Aust Date: 2014-02-17 Impact factor: 7.738

6. Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials.

Authors: D Y C Heng; T K Choueiri; B I Rini; J Lee; T Yuasa; S K Pal; S Srinivas; G A Bjarnason; J J Knox; M Mackenzie; U N Vaishampayan; M H Tan; S Y Rha; F Donskov; N Agarwal; C Kollmannsberger; S North; L A Wood
Journal: Ann Oncol Date: 2014-01 Impact factor: 32.976

7. The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts.

Authors:
Journal: Blood Date: 2013-04-25 Impact factor: 22.113